Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation

American Journal of Kidney Diseases

Volumn 55, Issue 6, 2010, Pages 1088-1096

  Patel, Rajan K ^a,b   Jardine, Alan G M ^a   Mark, Patrick B ^a,b   Cunningham, Anthony F ^b   Steedman, Tracey ^b   Powell, Joanna R ^a,b   McQuarrie, Emily P ^a,b   Stevens, Kathryn K ^a,b   Dargie, Henry J ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

cardiovascular magnetic resonance imaging (MRI); End stage renal disease; left atrial volume; left ventricular hypertrophy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BODY SURFACE; COHORT ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RATE; HEART VOLUME; HEMODIALYSIS; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATIENT REFERRAL; PREDICTION; PREOPERATIVE EVALUATION; RISK ASSESSMENT; SURVIVAL RATE; SYSTOLIC DYSFUNCTION;

EID: 77952582259     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.12.033     Document Type: Article

References (35)

1. Baigent C., Burbury K., and Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 356 9224 (2000) 147-152
2. Foley R.N., Parfrey P.S., Harnett J.D., et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 47 1 (1995) 186-192
3. Parfrey P.S., Foley R.N., Harnett J.D., Kent G.M., Murray D.C., and Barre P.E. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 11 7 (1996) 1277-1285
4. Mark P.B., Johnston N., Groenning B.A., et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 69 10 (2006) 1839-1845
5. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322 22 (1990) 1561-1566
6. Parfrey P.S., Harnett J.D., Griffiths S.M., et al. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 55 2 (1990) 114-120
7. Foley R.N., Parfrey P.S., Morgan J., et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int. 58 3 (2000) 1325-1335
8. Stewart G.A., Foster J., Cowan M., et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int. 56 6 (1999) 2248-2253
9. Myerson S.G., Bellenger N.G., and Pennell D.J. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 39 3 (2002) 750-755
10. Stewart G.A., Mark P.B., Johnston N., et al. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 24 6 (2004) 387-393
11. Gardin J.M., McClelland R., Kitzman D., et al. M-Mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 87 9 (2001) 1051-1057
12. Ristow B., Ali S., Whooley M.A., and Schiller N.B. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol. 102 1 (2008) 70-76
13. Abhayaratna W.P., Seward J.B., Appleton C.P., et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 47 12 (2006) 2357-2363
14. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification. Eur J Echocardiogr. 7 2 (2006) 79-108
15. Sievers B., Kirchberg S., Addo M., Bakan A., Brandts B., and Trappe H.J. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 6 4 (2004) 855-863
16. Scottish Renal Registry. The Scottish Renal Registry Report 2008. http://www.srr.scot.nhs.uk Accessed July 18, 2009
17. Patel R.K., Mark P.B., Johnston N., et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant. 8 8 (2008) 1673-1683
18. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 5 (2006) e84-e231
19. Alfakih K., Plein S., Thiele H., Jones T., Ridgway J.P., and Sivananthan M.U. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17 3 (2003) 323-329
20. Appleton C.P., Jensen J.L., Hatle L.K., and Oh J.K. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr. 10 3 (1997) 271-292
21. Nagueh S.F., Appleton C.P., Gillebert T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 10 2 (2009) 165-193
22. Collins A.J., Foley R., Herzog C., et al. Excerpts from the United States Renal Data System 2007 Annual Data Report. Am J Kidney Dis. 51 1 suppl 1 (2008) S1-S320
23. Herzog C.A., Mangrum J.M., and Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 21 4 (2008) 300-307
24. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 353 3 (2005) 238-248
25. Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 360 14 (2009) 1395-1407
26. Tripepi G., Benedetto F.A., Mallamaci F., Tripepi R., Malatino L., and Zoccali C. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens. 24 6 (2006) 1173-1180
27. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 341 23 (1999) 1725-1730
28. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 90 12 (2002) 1284-1289
29. Simek C.L., Feldman M.D., Haber H.L., Wu C.C., Jayaweera A.R., and Kaul S. Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr. 8 1 (1995) 37-47
30. Hornero F., Rodriguez I., Buendia J., et al. Atrial remodeling after mitral valve surgery in patients with permanent atrial fibrillation. J Card Surg. 19 5 (2004) 376-382
31. Tsao H.M., Wu M.H., Huang B.H., et al. Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fibrillation: insight from long-term follow-up of three-dimensional magnetic resonance imaging. J Cardiovasc Electrophysiol. 16 1 (2005) 7-12
32. Kuo C.S., Munakata K., Reddy C.P., and Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 67 6 (1983) 1356-1367
33. Mall G., Huther W., Schneider J., Lundin P., and Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 5 1 (1990) 39-44
34. Stack A.G., and Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis. 40 6 (2002) 1202-1210
35. Stewart G.A., Gansevoort R.T., Mark P.B., et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 67 1 (2005) 217-226